Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-250.49%Buyback Yield
VS
Market
Sector
Industry
History
$ 3.73Close
$ 3.39 - $ 60.74 52-Week Range
Ticker Information
Ticker
SLXNCompany Name
SILEXION THERAPEUTICS CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSILEXION THERAPEUTICS CORP - Buyback Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SLXN - Buyback Yield Historical data
| Date | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
|---|---|---|---|
| 6/30/2025 | -250.49% | $ 5.3M | $ 13.29M |
| 3/31/2025 | -159.87% | $ 8.43M | $ 13.48M |
| 12/31/2024 | -50.9% | $ 10.52M | $ 5.35M |
| 9/30/2024 | -3588.68% | $ 3.23M | $ 115.82M |
| 6/30/2024 | -254.68% | $ 35.63M | $ 90.75M |
| 3/31/2024 | 50.21% | $ 44.12M | $ -22.15M |
| 12/31/2023 | 260.01% | $ 43.42M | $ -112.9M |
| 9/30/2023 | 268.88% | $ 41.99M | $ -112.9M |
| 6/30/2023 | 133.91% | $ 67.77M | $ -90.75M |
| 3/31/2023 | 147.78% | $ 61.41M | $ -90.75M |
Key Performance Insights, Last 5 Years
- SILEXION THERAPEUTICS CORP's latest trailing twelve months (TTM) Buyback Yield stands at 0%.
- Over the past 5 years, SILEXION THERAPEUTICS CORP's average Buyback Yield has been -225.5%.
- The median Buyback Yield for SILEXION THERAPEUTICS CORP during this period was 0%
- SILEXION THERAPEUTICS CORP reached its highest Buyback Yield over the past 5 years at 268.88%.
- The lowest Buyback Yield recorded by SILEXION THERAPEUTICS CORP in the same timeframe -3588.68%
Similar metrics to CF - Equity:
- Payout Yield - [Calculation] The Payout Yield describes the percentage a business is returning to its shareholders in the form of share buybacks and dividends.
- Shareholder Yield - [Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Net Cash Flow - Issuance (Purchase) of Equity Shares - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).
Definition of Buyback Yield
[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.(-1 * CF - Equity) / Market Cap
(=) Buyback Yield Buyback Yield for SILEXION THERAPEUTICS CORP is calculated as follows: (-1 * CF - Equity [ $ 0 ]) / Market Cap [ $ 143.2M ]
(=) Buyback Yield [ 0% ] SLXN - Buyback Yield, Last 5 years
-3588.68%
Minimum
Sep 30, 2024
268.88%
Maximum
Sep 30, 2023
-225.5%
Average
0%
Median
Buyback Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
| filtered constituents | 3.28K |
|---|---|
| min | -8.43% |
| max | 8.43% |
| average | 0.64% |
| median | 0.01% |
| std | 2.71% |